Ocugen Files 8-K for Other Events and Exhibits
Ticker: OCGN · Form: 8-K · Filed: Dec 3, 2024 · CIK: 1372299
| Field | Detail |
|---|---|
| Company | Ocugen, INC. (OCGN) |
| Form Type | 8-K |
| Filed Date | Dec 3, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, corporate-update
Related Tickers: OCGN
TL;DR
OCGN filed an 8-K, likely with updates. Check for details.
AI Summary
Ocugen, Inc. filed an 8-K on December 3, 2024, to report other events and financial statements. The filing does not contain specific details about the nature of these events or financial figures within the provided text.
Why It Matters
This filing indicates Ocugen is providing updates or disclosures to the SEC, which could be material to investors.
Risk Assessment
Risk Level: low — The provided text is a standard 8-K filing header and does not contain specific operational or financial details that would indicate a high risk.
Key Numbers
- 001-36751 — SEC File Number (Identifies the company's filing history with the SEC.)
- 20241203 — Report Date (Date of the earliest event reported in the 8-K.)
Key Players & Entities
- Ocugen, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- Malvern, Pennsylvania (location) — Business Address
FAQ
What specific 'Other Events' are being reported by Ocugen, Inc. in this 8-K filing?
The provided text is a header and does not specify the 'Other Events' being reported.
What are the key financial statements or exhibits included with this 8-K filing?
The filing indicates that 'Financial Statements and Exhibits' are included, but the specific content is not detailed in the provided text.
What is the significance of the 'Conformed Submission Type' being 8-K?
An 8-K filing is a report of unscheduled material events or corporate changes that could be of interest to shareholders.
When was the earliest event reported in this filing?
The earliest event reported was on December 3, 2024.
What is Ocugen, Inc.'s Standard Industrial Classification (SIC) code and what does it represent?
Ocugen, Inc.'s SIC code is 2836, which corresponds to 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)'.
Filing Stats: 447 words · 2 min read · ~1 pages · Grade level 10.7 · Accepted 2024-12-03 09:50:00
Key Financial Figures
- $0.01 — ange on which registered Common Stock, $0.01 par value per share OCGN The Nasdaq Sto
Filing Documents
- ocgn-20241203.htm (8-K) — 26KB
- ocugenincpresentation.htm (EX-99.1) — 9KB
- ocugenincpresentation001.jpg (GRAPHIC) — 119KB
- ocugenincpresentation002.jpg (GRAPHIC) — 248KB
- ocugenincpresentation003.jpg (GRAPHIC) — 179KB
- ocugenincpresentation004.jpg (GRAPHIC) — 135KB
- ocugenincpresentation005.jpg (GRAPHIC) — 64KB
- ocugenincpresentation006.jpg (GRAPHIC) — 107KB
- ocugenincpresentation007.jpg (GRAPHIC) — 115KB
- ocugenincpresentation008.jpg (GRAPHIC) — 154KB
- ocugenincpresentation009.jpg (GRAPHIC) — 144KB
- ocugenincpresentation010.jpg (GRAPHIC) — 109KB
- ocugenincpresentation011.jpg (GRAPHIC) — 141KB
- ocugenincpresentation012.jpg (GRAPHIC) — 166KB
- ocugenincpresentation013.jpg (GRAPHIC) — 133KB
- ocugenincpresentation014.jpg (GRAPHIC) — 96KB
- ocugenincpresentation015.jpg (GRAPHIC) — 113KB
- ocugenincpresentation016.jpg (GRAPHIC) — 121KB
- ocugenincpresentation017.jpg (GRAPHIC) — 128KB
- ocugenincpresentation018.jpg (GRAPHIC) — 81KB
- ocugenincpresentation019.jpg (GRAPHIC) — 81KB
- ocugenincpresentation020.jpg (GRAPHIC) — 157KB
- ocugenincpresentation021.jpg (GRAPHIC) — 66KB
- ocugenincpresentation022.jpg (GRAPHIC) — 62KB
- ocugenincpresentation023.jpg (GRAPHIC) — 170KB
- ocugenincpresentation024.jpg (GRAPHIC) — 104KB
- ocugenincpresentation025.jpg (GRAPHIC) — 104KB
- 0001628280-24-049669.txt ( ) — 4426KB
- ocgn-20241203.xsd (EX-101.SCH) — 2KB
- ocgn-20241203_lab.xml (EX-101.LAB) — 21KB
- ocgn-20241203_pre.xml (EX-101.PRE) — 12KB
- ocgn-20241203_htm.xml (XML) — 3KB
01 Other Events
Item 8.01 Other Events. Attached as Exhibit 99.1 hereto and incorporated herein by reference is a presentation that Ocugen, Inc. will post on its website on December 3, 2024 and may use from time to time in presentations or discussions with investors, analysts, and other parties.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. The following exhibits are being furnished herewith: (d) Exhibits Exhibit No. Document 99.1 Ocugen, Inc. Presentation 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 3, 2024 OCUGEN, INC. By: /s/ Shankar Musunuri Name: Shankar Musunuri Title: Chairman, Chief Executive Officer, & Co-Founder 3